AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
This primer highlights crypto types considered safer for newcomers and outlines practical steps to assess risk and suitability for your first investments.
20,867 articlesAbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Morgan Stanley edges toward its 52-week high as earnings strength and wealth inflows support the rally. Analysts weig...
A veteran investor argues Talen Energy is undervalued versus its replacement cost, with potential for a doubling or m...
Starboard Value disclosed a dramatic reshuffle in its Q1 2026 13F, exiting Salesforce and Autodesk and plowing into L...
A federal judge invalidated the White House’s $100,000 H-1B filing fee, creating immediate uncertainty for U.S. emplo...
A smaller e-commerce stock jumped 25% in 2026, outpacing Amazon’s gains. This guide explains what’s driving the move,...
Retirees who keep working while collecting Social Security can face temporary benefit withholdings, but the money isn...
Mega IPOs grab headlines, but history often tells a different investing story. This article explains how spacex: hist...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...
News of a potential Iran peace deal sends crude prices lower, but mortgage rates look headed for a slower drop as inf...
A quiet revolution is unfolding in AI infrastructure. This article explains why the stock market underestimating mass...
CrowdStrike is moving to a 4-for-1 stock split. This guide breaks down what the split does, how it affects you as an ...